SD Biosensor Inc
KRX:137310
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SD Biosensor Inc
Other Current Assets
SD Biosensor Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SD Biosensor Inc
KRX:137310
|
Other Current Assets
₩150.6B
|
CAGR 3-Years
22%
|
CAGR 5-Years
124%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Other Current Assets
₩7.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Other Current Assets
₩4B
|
CAGR 3-Years
123%
|
CAGR 5-Years
97%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Other Current Assets
₩12B
|
CAGR 3-Years
39%
|
CAGR 5-Years
9%
|
CAGR 10-Years
39%
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Other Current Assets
₩909.1m
|
CAGR 3-Years
20%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Other Current Assets
₩10.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
51%
|
|
SD Biosensor Inc
Glance View
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2021-07-16. The firm is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The firm is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is SD Biosensor Inc's Other Current Assets?
Other Current Assets
150.6B
KRW
Based on the financial report for Dec 31, 2024, SD Biosensor Inc's Other Current Assets amounts to 150.6B KRW.
What is SD Biosensor Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
124%
Over the last year, the Other Current Assets growth was 157%. The average annual Other Current Assets growth rates for SD Biosensor Inc have been 22% over the past three years , 124% over the past five years .
